-
Stocks Gaining Momentum: EV Energy Partners LP (NASDAQ:EVEP), QUALCOMM (NASDAQ:QCOM), MiMedx Group (NASDAQ:MDXG), Bristol-Myers Squibb Co. (NASDAQ:BMY), KeyCorp. (NYSE:KEY)
EV Energy Partners, L.P. (NASDAQ:EVEP) Director George Lindahl III acquired 5,000 shares of EV Energy Partners, L.P. stock in a transaction dated Friday, January 16th. The shares were purchased at an average cost of $14.81 per share, for a total transaction of $74,050.00. Following the purchase, the director now directly owns 51,730 shares of the…
-
Healthcare Active Runners: Express Scripts Holding Company (NASDAQ:ESRX), Bristol-Myers Squibb (NYSE:BMY), Johnson & Johnson (NYSE:JNJ), AstraZeneca (NYSE:AZN)
Pharmacy benefit manager Express Scripts Holding Company (NASDAQ:ESRX) on Wednesday said it is too soon to know the significance of three government subpoenas it has received since February, which asked about the company’s business dealings with U.S. and European drugmakers. Shares of Express Scripts Holding Company (NASDAQ:ESRX)closed at $1.60 in last trading session. Yesterday share…
-
Drug Manufacturers Most Active: Pfizer Inc. (NYSE:PFE), Merck & Co. (NYSE:MRK), Bristol-Myers Squibb (NYSE:BMY), AstraZeneca (NYSE:AZN)
Pfizer Inc. (NYSE:PFE)’s $106 billion bid for AstraZeneca Plc (AZN) faces increased resistance as the unwilling target’s chairman listed the reasons the offer was rejected and British lawmakers began efforts to block the buyout attempt. Shares of Pfizer Inc. (NYSE:PFE) closed at $31.28 in last trading session. Yesterday share price of the company was traded…
-
Drug Most Active Stocks: GW Pharmaceuticals (NASDAQ:GWPH), Merck & Co., Inc. (NYSE:MRK), Bristol-Myers Squibb Co (NYSE:BMY), AstraZeneca (NYSE:AZN)
Shares of GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), which develops cannabis-based drugs, are climbing after Morgan Stanley initiated coverage of the stock with an Overweight rating and $103 price target in a note to investors earlier today. WHAT’S NEW: A small but growing set of data suggests that GW’s epilepsy treatments can help patients with refractory…
-
Hot Stocks: Merck & Co. (NYSE:MRK), Pfizer Inc. (NYSE:PFE), Johnson & Johnson (NYSE:JNJ), Bristol-Myers Squibb (NYSE:BMY)
Merck & Co (NYSE:MRK) EVP Clark Golestani sold 5,990 shares of the stock on the open market in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $55.47, for a total value of $332,265.30. Following the completion of the sale, the executive vice president now directly owns…
-
Drug Stocks: Johnson & Johnson (NYSE:JNJ), Eli Lilly (NYSE:LLY), Bristol-Myers Squibb Co (NYSE:BMY), Keryx Biopharmaceuticals (NASDAQ:KERX)
According to a news release from Yale University, Johnson & Johnson (NYSE:JNJ) has handed the Yale University Open Data Access (YODA) Project the keys to its clinical trial data vault. The agreement will give researchers worldwide access to the company’s extensive clinical trial data assets. Shares of Johnson & Johnson (JNJ) closed at $88.47 in…
-
Drug Manufacturer – Pfizer Inc. (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), AbbVie Inc (NYSE:ABBV), Keryx Biopharmaceuticals (NASDAQ:KERX)
A potential Pfizer Inc. (NYSE:PFE) treatment for an advanced form of lung cancer missed its main goals in two late-stage studies, but the drugmaker said it is still waiting for results from a third study. The New York company said Monday that dacomitinib failed to show a statistically significant improvement in progression-free survival in a…
-
Drug Sector Most Active Stock – Pfizer (NYSE:PFE), Merck (NYSE:MRK), Bristol-Myers Squibb (NYSE:BMY), Johnson & Johnson (NYSE:JNJ)
Pfizer Inc. (NYSE:PFE),one of the largest pharmaceutical companies in the world, participated in the Pioneering, Efficiency, Diversity and Distinctiveness Forum, which was held recently in Riyadh with the support of Labor Minister Adel Fakeih. Shares of Pfizer Inc. (NYSE:PFE) closed at $30.64 in last trading session. Yesterday share price of the company was traded in…
-
Hot Stocks – Johnson & Johnson (JNJ), Pfizer (PFE), Merck (MRK), Abbott Laboratories, Bristol-Myers (BMY), Eli Lilly
Johnson & Johnson (NYSE:JNJ) continues to fight an effort by plaintiffs in Risperdal lawsuits to procure the release of certain documents produced during discovery as part of a mass tort litigation underway in Pennsylvania’s Philadelphia Court of Common Pleas, Bernstein Liebhard LLP reports. Johnson & Johnson (NYSE:JNJ) shares fell -0.03% to $92.48 in current session.…
-
Health Stocks – Merck & Co. (NYSE:MRK), Pfizer Inc. (NYSE:PFE), Bristol-Myers Squib (NYSE:BMY), Johnson & Johnson (NYSE:JNJ)
Merck & Co., Inc. (NYSE:MRK) said it will begin twolate-stage trials of its experimental Alzheimer’s drug, one of the industry’s best hopes for slowing the memory-robbingdisease, after an independent monitoring board reviewed itssafety and recommended that more patients be recruited forstudies. Shares of Merck & Co., Inc. (NYSE:MRK) closed at $ 49.32 during last trading…